Blueprint Medicines(us:BPMC)
90.46
+0.14%
Updated on 2024-12-25
Open:90.77
Close:90.46
High:90.77
Low:89.22
Pre Close:90.33
Volume:113597.00
Amount:10.26M
Turnover:0.18%
Shares:63.53M
MarketCap:5.75B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 317 | 66057649 | 104.58% | 46 | 111 | 122 |
| 2024-03-31 | 299 | 65065282 | 103.95% | 48 | 100 | 113 |
| 2023-12-31 | 271 | 63968832 | 104.61% | 59 | 66 | 114 |
| 2023-09-30 | 240 | 64139055 | 105.59% | 26 | 95 | 81 |
| 2023-06-30 | 242 | 62702150 | 103.40% | 29 | 71 | 106 |
| 2023-03-31 | 240 | 62552618 | 103.54% | 28 | 89 | 92 |
| 2022-12-31 | 265 | 62598926 | 104.40% | 31 | 88 | 111 |
| 2022-09-30 | 271 | 62161915 | 103.94% | 40 | 69 | 125 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Blackrock Inc. | 6647297 | 10.52% | 199836 | 3.10% |
| 2024-06-30 | Vanguard Group Inc | 6538466 | 10.35% | 228489 | 3.62% |
| 2024-06-30 | Price T Rowe Associates Inc /Md/ | 5873392 | 9.30% | -377431 | -6.04% |
| 2024-06-30 | Fmr Llc | 4833684 | 7.65% | -335833 | -6.50% |
| 2024-06-30 | Wellington Management Group Llp | 3235555 | 5.12% | -939597 | -22.50% |
| 2024-06-30 | Rock Springs Capital Management Lp | 2460417 | 3.90% | -38031 | -1.52% |
| 2024-06-30 | State Street Corp | 2379884 | 3.77% | 187182 | 8.54% |
| 2024-06-30 | William Blair Investment Management, Llc | 1593916 | 2.52% | -114132 | -6.68% |
| 2024-06-30 | Geode Capital Management, Llc | 1459484 | 2.31% | 88357 | 6.44% |
| 2024-06-30 | Macquarie Group Ltd | 1312067 | 2.08% | 829 | 0.06% |
About
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Address:45 Sidney Street
Market Movers